Crinetics Pharmaceuticals, Inc. (CRNX)

NV5 Global Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	264.55	54.9	32.67	200.7	93.09
Short-Term Investments	-	1,090	503.66	301.75	133.01	77.79
Cash & Short-Term Investments	1,274	1,354	558.56	334.43	333.71	170.88
Cash Growth	47.65%	142.42%	67.02%	0.21%	95.29%	44.33%
Other Receivables	-	8.47	9.26	2.9	1.48	1.83
Receivables	-	8.47	9.26	2.9	1.48	1.83
Prepaid Expenses	-	10.43	4.56	3.51	7.2	1.72
Restricted Cash	-	0.5	-	-	-	-
Other Current Assets	-	1.92	1.78	4.36	2.34	3.06
Total Current Assets	-	1,375	574.15	345.18	344.72	177.49
Property, Plant & Equipment	-	55.58	57.43	4.99	4.72	5.41
Long-Term Investments	-	2	0.47	-	1.01	-
Other Long-Term Assets	-	1.63	3.3	2.01	0.57	0.54
Total Assets	-	1,435	635.35	352.18	351.02	183.45
Accounts Payable	-	5.85	6.55	6.88	3.42	3.49
Accrued Expenses	-	44.49	27.35	17.19	11.63	6.17
Current Portion of Leases	-	7.15	4.17	1.05	0.94	0.84
Current Unearned Revenue	-	2.18	2.06	2.24	-	-
Other Current Liabilities	-	0.01	3.82	0.36	-	-
Total Current Liabilities	-	59.68	43.94	27.72	16	10.49
Long-Term Leases	-	44.57	47.56	2.02	3.07	4.01
Long-Term Unearned Revenue	-	4.7	4.75	6.1	-	-
Other Long-Term Liabilities	-	0.83	-	-	0	0.02
Total Liabilities	-	109.79	96.25	35.85	19.07	14.53
Common Stock	-	2,276	1,192	759.43	607.58	336.51
Retained Earnings	-	-952.11	-653.7	-439.17	-275.26	-167.61
Comprehensive Income & Other	-	0.96	0.98	-3.93	-0.38	0.03
Total Common Equity	1,254	1,325	539.11	316.33	331.94	168.92
Shareholders' Equity	1,254	1,325	539.11	316.33	331.94	168.92
Total Liabilities & Equity	-	1,435	635.35	352.18	351.02	183.45
Total Debt	50.82	51.72	51.73	3.08	4.01	4.85
Net Cash (Debt)	1,223	1,302	506.83	331.35	329.69	166.03
Net Cash Growth	51.09%	156.96%	52.96%	0.50%	98.57%	47.17%
Net Cash Per Share	13.64	16.12	8.73	6.37	8.58	5.45
Filing Date Shares Outstanding	93.79	93.05	69.6	53.91	47.78	33.03
Total Common Shares Outstanding	93.79	92.93	68.18	53.88	47.6	33
Working Capital	-	1,316	530.21	317.46	328.73	167
Book Value Per Share	13.41	14.26	7.91	5.87	6.97	5.12
Tangible Book Value	1,254	1,325	539.11	316.33	331.94	168.92
Tangible Book Value Per Share	13.41	14.26	7.91	5.87	6.97	5.12
Machinery	-	7.9	6.11	4.07	2.79	2.25
Leasehold Improvements	-	11.9	9.84	3.52	3.52	3.49

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q